Basic Information
| LncRNA/CircRNA Name | HOXB13-AS1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | RNA-seq |
| Sample | LUAD tissues |
| Expression Pattern | differential expression |
| Function Description | Univariate and multivariate Cox regression analysis showed that 6 lncRNAs (FOXE1, HOXB13-AS1_2, VMO1, HIST1H3F, AJ003147.8, ASXL4) were retrieved to construct a predictive model associated with overall survival in LUAD patients. |
| Pubmed ID | 31558162 |
| Year | 2019 |
| Title | Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. |
External Links
| Links for HOXB13-AS1 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |